Immunoprecise Antibodies Ltd IPA

Technology Scientific & Technical Instruments

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd > anything going on

<< Previous

Bullboard Posts

Next >>

Comment by 007daveon Jun 07, 2021 2:59pm

245 Views

Post# 33341750

RE:RE:RE:RE:RE:RE:RE:RE:anything going on

Which master pumper are you referring to. IPA has been around along time and 90% of the executives are women and science based. Which is one reason the stock is down right now. IPA needs more market people that understand capital markets. They're on the NASDAQ now and need to step up their game.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario